ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,633.09
0.13%
Dow Jones
41,622.08
0.55%
US Dollar vs MXN
19.30054
0.42%
Brent Oil
72.10
-0.71%
Bitcoin
59,155.61
1.67%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
17/09/202405:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BAZNFBaozun Inc (PK)
17/09/202405:33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:LACLithium Americas Corp NEW
17/09/202405:33Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:SAGESage Therapeutics Inc
17/09/202405:33Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
17/09/202405:33PR Newswire (US)Cohere Beauty Marks Anniversary with Remarkable Post-Restructure Growth
17/09/202405:31Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:RFACWRF Acquisition Corporation
17/09/202405:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RFACWRF Acquisition Corporation
17/09/202405:30GlobeNewswire Inc.ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.NASDAQ:KLTOKlotho Neurosciences Inc
17/09/202405:30GlobeNewswire Inc.Ducommun to Participate in RBC Global Industrials ConferenceNYSE:DCODucommun Inc
17/09/202405:30Business WireWestwater Resources Announces Off-Take Agreement for Sale of 100% of Fines Graphite Production from its Kellyton PlantAMEX:WWRWestwater Resources Inc
17/09/202405:30Business WireHenry Schein to Serve as Exclusive Distributor of Curodont to Dental Service OrganizationsNASDAQ:HSICHenry Schein Inc
17/09/202405:30Business WireRecruit Rooster Wins Gold in the 2024 MUSE Creative Awards for Video Production
17/09/202405:30Business WireSITE Centers Provides Third Quarter 2024 Transaction and Spin-Off UpdateNYSE:SITCSITE Centers Corp
17/09/202405:30Business WireNura Bio Closes Series A Financing with $68 Million in New Funds, Bringing Total Raised to $140+ Million
17/09/202405:30Business WireAgellus Capital Completes Investment in BlackPoint IT Services
17/09/202405:30Business WireSITE Centers Announces Board of Directors and CFO AppointmentsNYSE:SITCSITE Centers Corp
17/09/202405:30PR Newswire (US)Sverica Capital Management Announces Growth Investment in FOUR Inc.
17/09/202405:30PR Newswire (US)VIAVI Introduces Innovative Benchtop Microscopy Solution at ECOC 2024NASDAQ:VIAVViavi Solutions Inc
17/09/202405:29PR Newswire (US)Ureteral Access Sheath Market to Reach $2.2 Billion, Globally, by 2033 at 5.5% CAGR: Allied Market Research
17/09/202405:28PR Newswire (US)Akamai Finds Geopolitical Tensions Driving Surge in DDoS Attacks on Financial InstitutionsNASDAQ:AKAMAkamai Technologies Inc
17/09/202405:26Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:AOGOWArogo Capital Acquisition Corporation
17/09/202405:25Alliance NewsAlliance NewsHarworth replaces Network International in FTSE 250 after buyoutLSE:HWGHarworth Group Plc
17/09/202405:25PR Newswire (US)Ascletis Enters the Obesity Drug Space with Announcement of Two Ongoing U.S. Phase I Clinical Trials Utilizing Its Small Molecule GLP-1R Agonist ASC30 for Both Once-Monthly Subcutaneous Injection and Once-Daily Oral Tablet for the Treatment of Obesity
17/09/202405:22PR Newswire (US)GoDaddy: AI Essentials For Small Businesses to Drive Growth and Save Time
17/09/202405:18PR Newswire (US)Metro Bank Forges Strategic Collaboration with Infosys to Accelerate Digital TransformationNYSE:INFYInfosys Limited
17/09/202405:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:DSSDSS Inc
17/09/202405:15PR Newswire (US)Skycorp's ARMAS Sensor to Fly Aboard Lonestar Data Holding's Freedom Payload on Intuitive Machines' Lunar Mission to the South Pole
17/09/202405:15PR Newswire (Canada)SOLLUM LANCE UNE NOUVELLE GAMME INNOVANTE DE PRODUITS ET SERVICES À L'AUBE DE SES 10 ANS
17/09/202405:13PR Newswire (US)SOLLUM UNVEILS AN INNOVATIVE NEW RANGE OF PRODUCTS AND SERVICES ON THE EVE OF ITS 10TH ANNIVERSARY
17/09/202405:10PR Newswire (US)Endera Unveils Next-Generation Continuous Evaluation Platform for Workforce Risk Management

Su Consulta Reciente

NYSE
VZ
Verizon Communications
AMEX
SPY
SPDR S&P 500
NASDAQ
MSFT
Microsoft
USOTC
BNPQY
BNP Paribas (QX)
COIN
XRPUSD
Ripple
COIN
DOGEUSD
Dogecoin
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
OILBRENT
Brent Oil
NYSE
XOM
Exxon Mobil
AMEX
XLV
Health Care Select Sector
NYSE
DIS
Walt Disney
USOTC
BASFY
BASF (QX)
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
TSLA
Tesla
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados